Table 3.
Effects of BCACs on Serum Levels of AOPP of Patients with OAG (BCACs, n=19 and Placebo Groups, n=19)
| |
AOPP (μmol/L) |
||||
|---|---|---|---|---|---|
| Group | 0 M | 6 M | 12 M | 18 M | 24 M |
| BCACs | 16.12±7.50 | 16.24±7.86 | 16.16±8.49 | 16.19±8.04 | 16.23±11.04 |
| Placebo | 16.06±12.12 | 16.13±9.24 | 16.18±7.56 | 16.38±8.16 | 16.22±8.40 |
Values shown are mean±SD.
No statistical differences between groups (2-way repeated measures ANOVA) and inter-groups (paired t-test) were observed.